Suppr超能文献

猕猴睾丸中的类固醇生成:酶组织与内源性类固醇、类固醇生成及促性腺激素治疗的关系。

Steroidogenesis in the monkey testis: relationship of enzyme organization to endogenous steroids, steroidogenesis and gonadotropin treatment.

作者信息

Yoshida K, Takahashi J, Winters S J, Oshima H, Troen P

出版信息

J Steroid Biochem. 1984 Jul;21(1):49-58. doi: 10.1016/0022-4731(84)90059-1.

Abstract

To explore testicular factors which determine steroidogenesis, circulating and intratesticular steroid levels were measured and in vitro steroidogenesis in testicular mines and microsomes was investigated using adult rhesus monkeys before and after treatment with pharmacological doses of hCG or hCG together with hMG. After gonadotropin treatment serum and intratesticular levels of 17 alpha-hydroxyprogesterone as well as end product testosterone were markedly elevated. Dynamic studies revealed that 17 alpha-hydroxyprogesterone produced from pregnenolone was partly metabolized to C19-steroids but almost no 17 alpha-hydroxyprogesterone produced from progesterone was utilized by C17-20 lyase. Androstenedione levels increased in serum after both treatments and were elevated in testis tissue after hCG treatment. Androstenedione accumulated in vitro during incubation of untreated and hCG-treated testes with [3H]pregnenolone and [14C]progesterone. The major portion of the accumulated androstenedione was produced from pregnenolone through dehydroepiandrosterone rather than through 17 alpha-hydroxyprogesterone, indicating differential availability of androstenedione to 17 beta-hydroxysteroid oxidoreductase according to its origin. The 3H/14C ratio in product androstenedione was much greater than the ration in product testosterone in both untreated and hCG-treated testis; in testes of animals treated with hCG together with hMG, the ratios in both products were closely linked. Among the enzymes examined, 17 alpha-hydroxylase and C17-20 lyase activities for 5-ene-C21-steroids were increased and 17 beta-hydroxysteroid oxidoreductase activity were decreased by gonadotropin treatment. Our findings confirm the phenomenon of unequal substrate availability to enzymes depending upon the provenance of the substrate and demonstrate that gonadotropin(s) change substrate availability as do direct changes in enzyme activities. The unequal substrate availability validates the assumption, previously proposed by others, that microsome enzymes have an organized arrangement as enzyme complexes.

摘要

为了探究决定类固醇生成的睾丸因素,我们测量了成年恒河猴在给予药理剂量的人绒毛膜促性腺激素(hCG)或hCG与人类绝经期促性腺激素(hMG)联合治疗前后的循环和睾丸内类固醇水平,并研究了睾丸匀浆和微粒体中的体外类固醇生成。促性腺激素治疗后,血清和睾丸内17α-羟孕酮以及终产物睾酮的水平显著升高。动态研究表明,由孕烯醇酮产生的17α-羟孕酮部分代谢为C19类固醇,但由孕酮产生的17α-羟孕酮几乎没有被C17-20裂解酶利用。两种治疗后血清中的雄烯二酮水平均升高,hCG治疗后睾丸组织中的雄烯二酮水平升高。在未处理和hCG处理的睾丸与[3H]孕烯醇酮和[14C]孕酮一起孵育期间,雄烯二酮在体外积累。积累的雄烯二酮的主要部分是由孕烯醇酮通过脱氢表雄酮产生的,而不是通过17α-羟孕酮产生的,这表明根据其来源,雄烯二酮对17β-羟类固醇氧化还原酶的可用性不同。在未处理和hCG处理的睾丸中,产物雄烯二酮中的3H/14C比值远大于产物睾酮中的比值;在hCG与hMG联合治疗的动物睾丸中,两种产物中的比值紧密相关。在所检测的酶中,促性腺激素治疗使5-烯-C21类固醇的17α-羟化酶和C17-20裂解酶活性增加,而17β-羟类固醇氧化还原酶活性降低。我们的研究结果证实了底物对酶的可用性因底物来源而异的现象,并表明促性腺激素改变底物可用性的方式与酶活性的直接变化相同。底物可用性的不平等验证了其他人先前提出的假设,即微粒体酶作为酶复合物具有有组织的排列。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验